Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIVSF162P3-Reference-Cited by-同舟云学术

Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIVSF162P3

Published:2011-07-22 Issue:4 Volume:40 Page:214-223
ISSN:0047-2565
Container-title:Journal of Medical Primatology
language:en
Short-container-title:

Author:

Henning Tara,Fakile Yetunde,Phillips Christi,Sweeney Elizabeth,Mitchell James,Patton Dorothy,Sturdevant Gail,Caldwell Harlan D.,Evan Secor W.,Papp John,Michael Hendry R.,McNicholl Janet,Kersh Ellen

Publisher

Wiley

Subject

General Veterinary,Animal Science and Zoology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0684.2011.00488.x/fullpdf

Reference46 articles.

1. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study;Laga;AIDS,1993

2. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection;Sexton;Sex Transm Dis,2005

3. Epidemiological study of phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between subtype B and non-B infections;Chalmet;BMC Infect Dis,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasmodium knowlesi in pig-tailed macaques: a potential new model for malaria vaccine research;Malaria Journal;2023-12-13

2. Plasmodium knowlesi in pig-tailed macaques: a new model for malaria vaccine research;2023-08-25

3. Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques;eBioMedicine;2022-12

4. Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites;Malaria Journal;2022-08-27

5. The predictive value of macaque models of preexposure prophylaxis for HIV prevention;Current Opinion in HIV and AIDS;2022-07